期刊文献+

健乳灵治疗大鼠乳腺增生的病理观察 被引量:15

Pathological Evaluation of Mammary Gland Hyperplasia Rats Treated with Jianruling
下载PDF
导出
摘要 目的:研究健乳灵对乳腺增生大鼠的治疗作用及对乳腺组织p16、p53表达的影响。方法: 75只大鼠随机分为5组,分别为正常对照组,模型组,高、中、低三个药物试验组。分别用不同剂量的健乳灵治疗60d,取乳腺组织观察乳腺的病理变化和p16、p53蛋白表达。结果:健乳灵三个剂量组均能抑制乳腺上皮增生,减少小叶和腺泡数目,降低大鼠乳腺增生组织的p16、p53蛋白表达水平, 与模型组比较有显著性差异(P<0. 01)。结论:健乳灵对大鼠乳腺增生病有调节和治疗作用。 Objective:To study the effect of Jianruling on the expression of p16 and p53 in rats with mammary gland hyperplasia. Methods:The model of mammary gland hyperplasia in female rats was established by intramuscular injection of estradiol and progesterone. The pathological changes of mammary gland were observed under light microscope,and the level of expression of p16 and p53 were measured by immunohistochemical method after treatment with Jianruling at dose of 0.842 g/(kg·d),1.684g/(kg·d) and 3.368 g/(kg·d) for 60 days. Results:Jianruling can inhibit mammary gland epithelial hyperplasia, reduce the quantity of lobules and acini,while the level of expression of p16 and p53 with mammary gland hyperplasia significantly decreased to lower than that of the model control group(P<0.01). Conclusion:Jianruling has positive effect on the adjustment and treatment of rats with mammary gland hyperplasia.
出处 《广州医学院学报》 2005年第1期33-37,共5页 Academic Journal of Guangzhou Medical College
基金 广东省中医药管理局(101047)
关键词 健乳灵 乳腺增生 病理变化 蛋白表达 hyperplasia of mammary gland Jianruling p16 p53 protein expression
  • 相关文献

参考文献10

二级参考文献26

  • 1张振东,李树玲.乳腺癌全乳腺切片的病理组织学研究:Ⅲ.伴发病变和癌旁病变[J].中华肿瘤杂志,1993,15(1):20-22. 被引量:14
  • 2姜军,陈意生,柳凤轩,詹新恩,马宏敏.乳腺不典型增生组织中ras基因产物表达的意义[J].第三军医大学学报,1996,18(3):202-205. 被引量:5
  • 3沃兴德,楼丽华,李万里,陈英,高承贤,洪行球,金明敏.乳腺康对乳腺增生病患者垂体—性腺激素周期节律的影响[J].中国中西医结合杂志,1996,16(10):600-603. 被引量:45
  • 4中华人民共和国中医药行业标准(国家中医药管理局发布).中医病证诊断疗效标准[M].南京:南京大学出版社,1994.45-46.
  • 5罗荣生.雌性甾体激素--受体复合物的生物特性与功能[J].生殖与避孕杂志,1993,3(1):11-11.
  • 6Hartwell LH, kastan MB. Cell cycle control and cancer. Science, 1994, 266 (5192): 1821--1828.
  • 7Sherr CJ. Cancer cell cycle. Science, 1996, 274(5293) : 1672--1677.
  • 8Michalides RJ. Cell cycle regulators: mechanisms and their role in aeliology, prognosis, and treatment of cancer. J Clinpathol, 1999, 52 (8): 555--568.
  • 9Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator Potentially involued in genesis of many tumor types. Science, 1994, 246 (5157): 436--440.
  • 10Hunter T, Pines T. Cyclins and cancer II : CyclinD and CDK inhibitors come of age. Cell, 1994, 79 (4) :573--582.

共引文献178

同被引文献134

引证文献15

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部